Yablonka Uri bought BCLI
February 26, 2026 · Form 4 insider transaction
Yablonka Uri bought 150,000 shares of Brainstorm Cell Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 92 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
InsiderYablonka Uri
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateMay 29, 2026
Shares owned after218,464
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.